Humana (NYSE:HUM) Sets New 1-Year High – Here’s Why

Humana Inc. (NYSE:HUM) shares hit a new 52-week high on Thursday . The company traded as high as $414.82 and last traded at $409.9230, with a volume of 1685093 shares trading hands. The stock had previously closed at $397.22.

Wall Street Analysts Forecast Growth

HUM has been the topic of a number of recent research reports. Robert W. Baird decreased their target price on Humana from $264.00 to $205.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Wolfe Research upgraded Humana from a “hold” rating to a “strong-buy” rating in a report on Thursday, June 4th. Oppenheimer raised shares of Humana from an “outperform” rating to an “outperform” rating in a research report on Wednesday, May 20th. JPMorgan Chase & Co. boosted their price objective on shares of Humana from $214.00 to $316.00 and gave the company a “neutral” rating in a research report on Monday, June 8th. Finally, Morgan Stanley lifted their price target on Humana from $217.00 to $249.00 and gave the company an “underweight” rating in a report on Thursday, June 4th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, sixteen have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat, Humana currently has a consensus rating of “Hold” and a consensus price target of $293.09.

Humana Price Performance

The company has a market capitalization of $49.22 billion, a price-to-earnings ratio of 43.84, a P/E/G ratio of 2.26 and a beta of 0.71. The stock has a fifty day simple moving average of $314.71 and a 200-day simple moving average of $248.64. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, topping analysts’ consensus estimates of $9.97 by $0.34. The business had revenue of $39.65 billion for the quarter, compared to analysts’ expectations of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business’s revenue was up 23.5% on a year-over-year basis. During the same quarter last year, the company earned $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. On average, equities research analysts anticipate that Humana Inc. will post 9.04 EPS for the current year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 0.9%. The ex-dividend date is Friday, June 26th. Humana’s dividend payout ratio (DPR) is currently 37.86%.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Montag A & Associates Inc. increased its stake in shares of Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 94 shares in the last quarter. CoreCap Advisors LLC boosted its position in Humana by 54.4% during the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 37 shares in the last quarter. Fideuram Asset Management Ireland dac purchased a new position in Humana during the fourth quarter worth approximately $27,000. Reflection Asset Management acquired a new stake in Humana in the fourth quarter valued at approximately $29,000. Finally, Rosenberg Matthew Hamilton increased its position in shares of Humana by 136.0% in the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after buying an additional 68 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.